Once-daily venlafaxine extended-release tablets available

Osmotica Pharmaceutical and Upstate Pharma, a subsidiary of UCB, have made available venlafaxine extended-release tablets in 37.5mg, 75mg, 150mg, and 225mg dosage strengths.

Venlafaxine extended-release tablets are indicated for the treatment of major depressive disorder (MDD) and social anxiety disorder (SAD).

For more information call (888) 299-1053 or visit www.vertablets.com.